Publications (44) Jesus Carlos Fernandez López publications

2024

  1. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine, Vol. 129, pp. 78-86

  2. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

    BMC musculoskeletal disorders, Vol. 24, Núm. 1, pp. 246

  2. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

2022

  1. PROCOAC (PROspective COhort of A Coruña) description: Spanish prospective cohort to study osteoarthritis

    Reumatologia Clinica, Vol. 18, Núm. 2, pp. 100-104

  2. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

2021

  1. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 13

2020

  1. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

    Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916

  2. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

  3. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

  4. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice

    Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119

2019

  1. Objectives and methodology of BIOBADASER phase III

    Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236

  2. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135

2017

  1. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis

    Rheumatology (United Kingdom), Vol. 56, Núm. 2, pp. 263-270

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  3. Mitochondrial DNA haplogroups influence the risk of incident knee osteoarthritis in OAI and CHECK cohorts. A meta-Analysis and functional study

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 1114-1122

  4. Prevalencia de patología podológica, funcionalidad y dolor del pie en personas con artritis reumatoide y psoriásica

    XXI Encuentro Internacional de Investigación en Cuidados

2015

  1. Body mass index and doses at organs at risk in a mediterranean population treated with postoperative vaginal cuff brachytherapy

    Cancer Research and Treatment, Vol. 47, Núm. 3, pp. 473-479

  2. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy

    Brachytherapy, Vol. 14, Núm. 4, pp. 458-463

  3. Mitochondrial DNA haplogroups modulate the radiographic progression of Spanish patients with osteoarthritis

    Rheumatology International, Vol. 35, Núm. 2, pp. 337-344